Association Between Patient Cost Sharing and Cardiac Rehabilitation Adherence
Author Department
Internal Medicine; Cardiology; Medicine; Healthcare Quality
Document Type
Article, Peer-reviewed
Publication Date
12-2019
Abstract
OBJECTIVE:
To determine the association between cost sharing and adherence to cardiac rehabilitation (CR).
PATIENTS AND METHODS:
We collected detailed cost-sharing information for patients enrolled in CR at Baystate Medical Center in Springfield, Massachusetts, including the presence (or absence) and amounts of co-pays and deductibles. We evaluated the association between cost sharing and the total number of CR sessions attended as well as the influence of household income on CR attendance.
RESULTS:
In 2015, 603 patients enrolled in CR had complete cost-sharing information. In total, 235 (39%) had some form of cost sharing. Of these, 192 (82%) had co-pays (median co-pay, $20; interquartile range [IQR], $10-$32) and 79 (34%) had an unmet deductible (median, $500; IQR, $250-$1800). The presence of any amount or form of cost sharing was associated with 6 fewer sessions of CR (16; IQR, 4-36 vs 10; IQR, 4-27; P<.001). Patients hospitalized in November or December with deductibles that renewed in January attended 4.5 fewer sessions of CR (8.5; IQR, 3.25-12.50 vs 13; IQR, 5.25-36.00; P=.049). After adjustment for differences in baseline characteristics, every $10 increase in co-pay was associated with 1.5 (95% CI, -2.3 to -0.7) fewer sessions of CR (P<.001). Household income did not moderate these relationships.
CONCLUSION:
Cost sharing was associated with lower CR attendance and exhibited a dose-response relationship such that higher cost sharing was associated with lower CR attendance. Given that CR is cost-effective and underutilized, insurance companies and other payers should reevaluate their cost-sharing policies for CR.
Recommended Citation
Farah M, Abdallah M, Szalai H, Berry R, Lagu T, Lindenauer PK, Pack QR. Association Between Patient Cost Sharing and Cardiac Rehabilitation Adherence. Mayo Clin Proc. 2019 Dec;94(12):2390-2398.
PMID
31806097